Abstract

REVIEW ON RECENT EMERGENCE OF NOVEL CORONA VIRUS 2019.

*Premjit S. Nannaware and S. D. Mankar

Abstract

The Covid 19 belongs to the family of virus that causes viral pneumonia including fever, breathing difficulty, and lung infection. These viruses are common in animals worldwide, but very few of them are known to affect humans. The World Health Organization (WHO) used the term 2019 novel coronavirus (2019-nCoV) to refer to the covid 19 that was diagnosed from the lower respiratory tract of patients with pneumonia infection in Wuhan, China on 29 December, 2019. It was appear that the human infection of the virus originated from the local Huanan South China Seafood Market in Wuhan, Hubei Province, China. This epidemic had spread to 19 countries with 11,791 confirmed cases, including 213 deaths, as of January 31, 2020. The most commonly reported symptoms are cough, fever, myalgia or fatigue, pneumonia and complicated dyspnea, whereas less common reported symptoms include headache, diarrhea, hemoptysis, runny nose, and phlegm-producing cough. For patients with suspected infection, performing realtime fluorescence RT-PCR to detect the positive nucleic acid of 2019-nCoV in sputum, throat swabs, and secretions of the lower respiratory tract samples This study analyzed and discussed for a better understanding of the epidemiology, causes, pathology, transmission, virology, clinical diagnosis, treatment, Vaccine research, prevention and control of this virus. To date, no specific antiviral treatment has been confirmed to be effective. With regard to, infected patients with 2019-nCoV, it has been recommended to apply appropriate symptomatic treatment and supportive care.

Keywords: Covid 19, viral, pneumonia, epidemiology, diagnosis, treatment, Vaccine, research.